Three stocks rose for every one that fell on the NYSE today Print E-mail
By Staff and Wire Reports   
Wednesday, 05 October 2011 15:36
FDA approvalSigns of growth in the U.S. economy also pushed stocks higher and growth in the service sector was in line with Wall Street's expectations. It was reported that private companies added 91,000 jobs last month.
Stocks rose sharply higher for a second straight day on signs that European officials are moving to support the region's struggling banks.

Analysts said the gains were triggered by reports that European officials are exploring ways to limit the damage should the Greek government default on its debt.

In the healthcare sector, there were several multi-point gainers for the first time in several sessions. Shares of Orexigen (NASDAQ:OREX) rose 14% after bouncing off newly formed technical support levels just under the $2 level. The biopharmaceutical company focused on the treatment of obesity's approach involves taking advantage of the synergy between established products, combined with novel science, resulting in unique mechanisms of action that act on the central nervous system. The company's drug combinations are designed to initiate and sustain weight loss by reducing appetite and increasing metabolism. The Company's lead product candidates are - 1) Contrave® is an investigational medication for the treatment of obesity; and 2) Empatic(TM) is a fixed-dose combination of zonisamide sustained release (SR) and bupropion SR.

Gainers (% price change) Last Trade Change Mkt Cap
Orexigen Therapeutics OREX 2.19 +0.27 (14.06%) 105.31M
Insmed Incorporated INSMD 4.71 +0.41 (9.53%) 116.96M
Alphatec Holdings, Inc. ATEC 2.23 +0.18 (8.78%) 198.97M
Brookdale Senior Living BKD 12.86 +1.03 (8.71%) 1.57B
Array BioPharma Inc. ARRY 2.13 +0.16 (8.12%) 121.45M
Losers (% price change)
Cornerstone Therapeutics CRTX 6.26 -0.79 (-11.21%) 162.48M
MELA Sciences, Inc. MELA 5.49 -0.43 (-7.31%) 138.62M
Palomar Medical Tech PMTI 7.94 -0.52 (-6.15%) 151.10M
Cadence Pharmaceuticals CADX 6.52 -0.42 (-6.05%) 414.77M
MannKind Corporation MNKD 3.49 -0.21 (-5.68%) 457.08M
Most Actives (dollar volume)
Pfizer Inc. PFE 17.98 +0.39 (2.22%) 140.28B
Johnson & Johnson JNJ 62.35 +0.18 (0.29%) 170.86B
Merck & Co., Inc. MRK 31.46 +0.11 (0.35%) 96.92B
Bristol Myers Squibb Co. BMY 32.73 +0.64 (1.99%) 55.83B
Pharmaceutical Product PPDI 31.90 -0.04 (-0.13%) 3.63B



"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter